A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Peer Review reports

Original Submission
18 Oct 2018	Submitted	Original manuscript
8 Dec 2018	Reviewed	Reviewer Report - Chia-Chi Lin
16 Dec 2018	Reviewed	Reviewer Report - Yasuo Hamamoto
20 Feb 2019	Author responded	Author comments - Nadja Meindl-Beinker
Resubmission - Version 2
20 Feb 2019	Submitted	Manuscript version 2
24 Feb 2019	Reviewed	Reviewer Report - Yasuo Hamamoto
26 Feb 2019	Author responded	Author comments - Nadja Meindl-Beinker
Resubmission - Version 3
26 Feb 2019	Submitted	Manuscript version 3
Publishing
7 Mar 2019	Editorially accepted
14 Mar 2019	Article published	10.1186/s12885-019-5446-2

Back to article page